Table 3.
Types of AEFI reported among the study participants (N = 1826)
| Type of AEFI | Total (N = 1826), N (%) | First dose (N = 23), N (%) | Second dose (N = 1303), N (%) | p value |
|---|---|---|---|---|
| Pain at the injection site | 267 (14.6) | 134 (25.6) | 133 (10.2) | <0.001 |
| Tenderness/soreness | 78 (4.3) | 23 (4.4) | 55 (4.2) | 0.898 |
| Redness/erythema | 4 (0.2) | 1 (0.2) | 3 (0.2) | 1.000 |
| Swelling/induration | 11 (0.6) | 6 (1.1) | 5 (0.4) | 0.057 |
| Itching/pruritus associated with injection | 1 (0.1) | 1 (0.2) | 0 (0.0) | 0.286 |
| Pain | 10 (0.5) | 5 (1.0) | 5 (0.4) | 0.134 |
| Fever | 178 (9.7) | 55 (10.5) | 123 (9.4) | 0.483 |
| Nausea/vomiting | 8 (0.4) | 4 (0.8) | 4 (0.3) | 0.181 |
| Headache | 104 (5.7) | 37 (7.1) | 67 (5.1) | 0.107 |
| Fatigue | 88 (4.8) | 19 (3.6) | 69 (5.3) | 0.134 |
| Muscle pain/myalgia | 107 (5.9) | 27 (5.2) | 80 (6.1) | 0.422 |
| Rash | 13 (0.7) | 1 (0.2) | 12 (0.9) | 0.094 |
| Joint pain | 2 (0.1) | 2 (0.4) | 0 (0.0) | 0.026 |
| Others | 3 (0.1) | 1 (0.2) | 2 (0.2) | 0.857 |
| Individuals having any AEFI | 544 (29.8) | 199 (38.1) | 345 (26.4) | <0.001 |
Abbreviation: AEFI, adverse events following immunization.